A Homogenous Bioluminescent System for Measuring GTPase, GTPase Activating Protein, and Guanine Nucleotide Exchange Factor Activities

Assay and Drug Development Technologies

Volumn 13, Issue 8, 2015, Pages 444-455

  Mondal, Subhanjan ^a   Hsiao, Kevin ^a   Goueli, Said A ^a,b  

^a PROMEGA CORPORATION   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE DERIVATIVE; LUCIFERASE; LUCIFERIN; NUCLEOSIDE DIPHOSPHATE KINASE; RECOMBINANT PROTEIN;

ARTICLE; CELL LYSATE; COMPETITIVE INHIBITION; ENZYME ACTIVITY; ENZYME ASSAY; ESCHERICHIA COLI; HYDROLYSIS; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; SACCHAROMYCES CEREVISIAE; SCREENING TEST; ENZYME ACTIVATION; LUMINESCENCE; METABOLISM; PHYSIOLOGY; PROCEDURES;

ENZYME ACTIVATION; GTP PHOSPHOHYDROLASES; GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; LUMINESCENT MEASUREMENTS;

EID: 84944460611     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2015.643     Document Type: Article

References (57)

1. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature 2002;420:629-635.
2. Downward J: Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003;3:11-22.
3. Colicelli J: Human RAS superfamily proteins and related GTPases. Sei STKE 2004;2004:RE13.
4. McEwen DP, Gee KR, Kang HC, Neubig RR: Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins. Anal Biochem 2001;291:109-117.
5. Malinski JA, Zera EM, Angleson JK, Wensel TG: High affinity interactions of GTPgammaS with the heterotrimeric G protein, transducin. Evidence at high and low protein concentrations. J Biol Chem 1996;271:12919-12924.
6. Kjeldgaard M, Nyborg J, Clark BF: The GTP binding motif: variations on a theme. FASEB J 1996;10:1347-1368.
7. Herrmann C: Ras-effeetor interactions: after one decade. Curr Opin Struct Biol 2003;13:122-129.
8. Vigil D, Cherfils J, Rossman KL, Der CJ: Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 2010; 10:842-857.
9. Bos JL, Rehmann H, Wittinghofer A: GEFs and GAPs: critical elements in the control of small G proteins. Cell J 2007;129:865-877.
10. Goody RS: How not to do kinetics: examples involving GTPases and guanine nucleotide exchange factors. FEB5 J 2014;281:593-600.
11. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
12. Lin R, Bagrodia S, Cerione R, Manor D: A novel Cdc42Hs mutant induces cellular transformation. Curr Biol 1997;7:794-797.
13. Hall A, Self AJ: The effect of Mg2+ on the guanine nucleotide exchange rate of p21N-ras. J Biol Chem 1986;261:10963-10965.
14. Zhang B, Zhang Y, Wang Z, Zheng Y: The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins. J Biol Chem 2000;275:25299-25307.
15. Kleuss C, Raw AS, Lee E, Sprang SR, Gilman AG: Mechanism of GTP hydrolysis by G-protein alpha subunits. Proc Natl Acad Sei USA 1994; 91:9828-9831.
16. Quan A, Robinson PJ: Rapid purification of native dynamin I and colorimetric GTPase assay. Methods Enzymol 2005;404:556-569.
17. Karl DM: A rapid sensitive method for the measurement of guanine ribonucleotides in bacterial and environmental extracts. Anal Biochem 1978; 89:581-595.
18. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A: Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 1997; 15:2755-2765.
19. Ford SR, Leach FR: Bioluminescent assay of the guanylates. Methods Mol Biol 1998;102:55-68.
20. Ford SR, Vaden VR, Booth JL, Hall MS, Webster JJ, Leach FR: Bioluminescent determination of 0.1 picomole amounts of guanine nucleotides. J Biolumin Chemilumin 1994;9:251-265.
21. Scheffzek K, Ahmadian MR, Wiesmuller L, et al: Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J 1998; 17:4313-4327.
22. Xu GF, O'Connell P, Viskochil D, et al: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608.
23. Corbett AH, Koepp DM, Schlenstedt G, Lee MS, Hopper AK, Silver PA: Rnalp, a Ran/TC4 GTPase activating protein, is required for nuclear import. J Cell Biol 1995;130:1017-1026.
24. Hillig RC, Renault L, Vetter IR, Drell T, 4th, Wittinghofer A, Becker J: The crystal structure of rnalp: a new fold for a GTPase-activating protein. Mol Cell 1999;3:781-791.
25. Pacold ME, Suire S, Perisic O, et al: Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 2000; 103:931-943.
26. Li G, D'Souza-Schorey C, Barbieri MA, Cooper JA, Stahl PD: Uncoupling of membrane ruffling and pinocytosis during Ras signal transduction. J Biol Chem 1997;272:10337-10340.
27. Dasso M: The Ran GTPase: theme and variations. Curr Biol 2002;12:R502-R508.
28. Renault L, Kuhlmann J, Henkel A, Wittinghofer A: Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1). Cell 2001;105:245-255.
29. Ohana RF, Hurst R, Vidugiriene J, Slater MR, Wood KV, Urh M: HaloTag-based purification of functional human kinases from mammalian cells. Protein Expr Purif 2011;76:154-164.
30. Chumanov RS, Kuhn PA, Xu W, Burgess RR: Expression and purification of full-length mouse CARM1 from transiently transfected HEK293T cells using HaloTag technology. Protein Expr Purif 2011;76:145-153.
31. Klebe C, Bischoff FR, Ponstingl H, Wittinghofer A: Interaction of the nuclear GTP-binding protein Ran with its regulatory proteins RCC1 and RanGAPI. Biochemistry 1995;34:639-647.
32. Bischoff FR, Ponstingl H: Catalysis of guanine nucleotide exchange of Ran by RCC1 and stimulation of hydrolysis of Ran-bound GTP by Ran-GAPI. Methods Enzymol 1995;257:135-144.
33. Bischoff FR, Ponstingl H: Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature 1991;354:80-82.
34. Vetter IR, Wittinghofer A: The guanine nucleotide-binding switch in three dimensions. Science 2001;294:1299-1304.
35. Scheffzek K, Ahmadian MR, Wittinghofer A: GTPase-activating proteins: helping hands to complement an active site. Trends Biochem Sei 1998; 23:257-262.
36. Eberhard DA, Johnson BE, Amler LC, et al: Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 2005;23:5900-5909.
37. Lièvre A, Bachet JB, Boige V, et al: KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 2008;26:374-379.
38. Berndt N, Hamilton AD, Sebti SM: Targeting protein prenylation for cancer therapy, "of Rev Cancer 2011 ;11:775-791.
39. Spiegel J, Cromm PM, Zimmermann G, Grossmann TN, Waldmann H: Small-molecule modulation of Ras signaling. Nat Chem Biol 2014;10:613-622.
40. Zimmermann G, Papke B, Ismail S, et al: Small molecule inhibition of the KRAS-PDEdelta interaction impairs oncogenic KRAS signalling. Nature 2013;497: 638-642.
41. Stephen AG, Esposito D, Bagni RK, McCormick F: Dragging ras back in the ring. Cancer Cell 2014;25:272-281.
42. Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM: K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 2013;503:548-551.
43. Burns MC, Sun Q, Daniels RN, et al: Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange. Proc Natl Acad Sei USA 2014;111:3401-3406.
44. Aktories K: Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 2011 ;9:487-498.
45. Ham H, Sreelatha A, Orth K: Manipulation of host membranes by bacterial effectors, "of Rev Microbiol 2011 ;9:635-646.
46. Boquet P, Lemichez E: Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis? Trends Cell Biol 2003;13:238-246.
47. Yaku H, Sasaki T, Takai Y: The Dbl oncogene product as a GDP/GTP exchange protein for the Rho family: its properties in comparison with those of Smg GDS. Biochem Biophys Res Commun 1994;198:811-817.
48. Eberth A, Ahmadian MR: In vitro GEF and GAP assays. Curr Protoc Cell Biol 2009;Chapter 14:Unit 14.9.
49. Richnau N, Aspenstrom P: Rich, a rho GTPase-activating protein domain-containing protein involved in signaling by Cdc42 and Rad. J Biol Chem 2001 ;276:35060-35070.
50. Self AJ, Hall A: Measurement of intrinsic nucleotide exchange and GTP hydrolysis rates. Methods Enzymol 1995;256:67-76.
51. Ellerbroek SM, Wennerberg K, Arthur WT, et al: SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis. Mol Biol Cell 2004;15:3309-3319.
52. Abe K, Rossman KL, Liu B, et al: Vav2 is an activator of Cdc42, Rad, and RhoA. J Biol Chem 2000;275:10141-10149.
53. McEwen DP, Gee KR, Kang HC, Neubig RR: Fluorescence approaches to study G protein mechanisms. Methods Enzymol 2002;344:403-420.
54. Marshall CB, Meiri D, Smith MJ, et al.: Probing the GTPase cycle with realtime NMR: GAP and GEF activities in cell extracts. Methods 2012;57:473-485.
55. Mazhab-Jafari MT, Marshall CB, Smith M, et al:. Real-time NMR study of three small GTPases reveals that fluorescent 2'(3')-0-(N-methylanthraniloyl)-tagged nucleotides alter hydrolysis and exchange kinetics. J Biol Chem 2010; 285:5132-5136.
56. Zielinski T, Kimple AJ, Hutsell SQ, Koeff MD, Siderovski DP, Lowery RG: Two Galpha(il) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity. J Biomol Screen 2009;14:1195-1206.
57. Zegzouti H, Zdanovskaia M, Hsiao K, Goueli SA: ADP-GIo: a bioluminescent and homogeneous ADP monitoring assay for kinases. Assay Drug Dev Technol 2009;7:560-572.